Carotid angioplasty and stenting: caveat emptor!

Vincent Thijs1

  • 1Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

Acta Neurologica Belgica
|February 28, 2007
PubMed

Insights

Carotid endarterectomy is effective for preventing stroke in patients with high-grade carotid stenosis. Carotid stenting requires further evaluation before widespread adoption, as current trials show mixed results.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiovascular Medicine

Background:

  • High-grade carotid stenosis poses a significant stroke risk.
  • Carotid endarterectomy (CEA) is an established treatment for reducing stroke risk in specific patient groups.
  • Carotid artery stenting (CAS) is an alternative treatment option.

Purpose of the Study:

  • To evaluate the effectiveness of carotid endarterectomy (CEA) versus carotid artery stenting (CAS) in preventing stroke.
  • To assess the current evidence base for CAS compared to CEA.

Main Methods:

  • Review of randomized trials comparing CEA and CAS.
  • Analysis of existing clinical data on stroke reduction in patients with transient ischemic attack (TIA) or minor stroke.
  • Evaluation of outcomes in asymptomatic male patients younger than 75 years with high-grade stenosis.

Main Results:

  • Carotid endarterectomy (CEA) effectively reduces stroke incidence in patients with TIA or minor stroke and high-grade carotid stenosis.
  • CEA is also beneficial for asymptomatic males under 75 with high-grade stenosis.
  • Carotid artery stenting (CAS) has been less thoroughly evaluated in randomized trials, with existing studies showing either inferior results or suggesting equivalence to CEA.

Conclusions:

  • Carotid endarterectomy remains a proven effective treatment for select patients with high-grade carotid stenosis.
  • Carotid artery stenting requires more rigorous evaluation through randomized trials before it can be considered a mainstream treatment.
  • Further critical assessment of CAS is needed, similar to the extensive evaluation CEA underwent previously.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...